Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Sabine Cerny-Reiterer, Anja Rabenhorst, Gabriele Stefanzl, Susanne Herndlhofer, Gregor Hoermann, Leonhard Müllauer, Sigrid Baumgartner, Christine Beham-Schmid, Wolfgang R. Sperr, Christine Mannhalter, Heinz Sill, Werner Linkesch, Michel Arock, Karin Hartmann, Peter Valent
Published Dec 26, 2014 · Vol. 6, No. 5 · pp. 3071-3084
Sara Correia Marques, Maria Bach Laursen, Julie Støve Bødker, Malene Krag Kjeldsen, Steffen Falgreen, Alexander Schmitz, Martin Bøgsted, Hans Erik Johnsen, Karen Dybkaer
Emmy D.G. Fleuren, Melissa H.S. Hillebrandt-Roeffen, Uta E. Flucke, D. Maroeska W.M. te Loo, Otto C. Boerman, Winette T.A. van der Graaf, Yvonne M.H. Versleijen-Jonkers
Published Nov 15, 2014 · Vol. 5, No. 24 · pp. 12753-12768